500 filings
Page 6 of 25
6-K
3uogmiev5
21 Dec 23
Current report (foreign)
10:19am
6-K
x5t5nuy x7nh81fe
19 Dec 23
Current report (foreign)
10:08am
6-K
jkx8jf
18 Dec 23
Current report (foreign)
10:28am
6-K
r7z64dy7tr1e6b3c
14 Dec 23
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014
12:29pm
6-K
aa7qn2uq9n0mcjox0e
13 Dec 23
Current report (foreign)
10:11am
6-K
xkquo
11 Dec 23
Current report (foreign)
11:39am
6-K
kgicz 19x7n4ohz
11 Dec 23
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
11:26am
6-K
7xwhrr7y
7 Dec 23
Current report (foreign)
10:13am
6-K
hv5zxod fed
6 Dec 23
Current report (foreign)
10:44am
6-K
bp0m6otxnltz j3
5 Dec 23
Current report (foreign)
10:13am
6-K
e085i 35n
4 Dec 23
Current report (foreign)
10:06am
6-K
zx88jz mn
1 Dec 23
Current report (foreign)
10:23am
6-K
l92bi
30 Nov 23
Current report (foreign)
11:19am
6-K
gxd8pv7tu79ypf3yx
29 Nov 23
Current report (foreign)
10:26am
6-K
edpuioh
27 Nov 23
Current report (foreign)
10:14am
6-K
fb536jogbx19
24 Nov 23
Current report (foreign)
6:04am
6-K
9pp6075xc0k17
22 Nov 23
Current report (foreign)
10:41am
6-K
iy3mev6qk7w ifqa
21 Nov 23
Topline Results Phase 3 MANIFEST-2 Study Pelabresib in First-Line Myelofibrosis November 2023 Gail, Living with Myelofibrosis since 2018
10:08am
6-K
yk1s1rlto4 xas8s
20 Nov 23
Current report (foreign)
4:55pm
6-K
0kv9ejypm4q6 y91
20 Nov 23
Current report (foreign)
10:06am